SCHEMBL1119258

SCHEMBL1119258

Oc1ccc(-c2oc3c(C(F)F)cc(O)cc3c2-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ HSD17B10 Q99714 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ ESR1 P03372 5/20 0.36
▸ ESR2 Q92731 5/20 0.36
▸ MMP3 P08254 1/20 0.36
▸ BCL2L1 Q07817 1/20 0.36
▸ ERAP1 Q9NZ08 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1119212 0.87 MEN1 (0.39) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL1119208 0.83 PDE4A (0.44) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL13665183 0.81 HSD17B10 (0.42) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL1119204 0.80 ESR1 (0.46) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL1119216 0.80 ESR2 (0.46) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL1119210 0.77 ESR2 (0.50) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL12596035 0.77 ESR2 (0.46) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL1119237 0.76 ESR1 (0.47) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL1119196 0.76 ESR1 (0.47) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1
SCHEMBL13665499 0.76 MEN1 (0.39) MEN1KMT2AHSP90AA1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112142-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-05-12 — — US claimed
CN-101998852-A Novel estrogen receptor ligands KAROBIO AB 2011-03-30 — — CN claimed
EP-2280699-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-02-09 — — EP claimed
WO-2009124968-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2009-10-15 — — WO claimed
US-20110112142-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-05-12 — — US disclosed
US-20110112142-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-05-12 — — US disclosed
US-20110112142-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-05-12 — — US disclosed
CN-101998852-A Novel estrogen receptor ligands KAROBIO AB 2011-03-30 — — CN disclosed
EP-2280699-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2011-02-09 — — EP disclosed
WO-2009124968-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2009-10-15 — — WO disclosed
WO-2009124968-A1 NOVEL ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2009-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112142-A1 NOVEL ESTROGEN RECEPTOR LIGANDS ESR2, ESR1, ESRRA MEN1 4374/4885KMT2A 1162/4885HSP90AA1 3613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback